Our Nu.Q® NETs assay detects diseases associated with NETosis, such as sepsis.
Who: St Guy’s and St Thomas’
About: Our latest trial is with Guy’s and St Thomas’ NHS Foundation Trust who are running a 500-patient study in critically unwell patients with sepsis in a real-world clinical setting. This is the first time a test to detect NETs directly has been brought to the bedside.
Who: Hospice Civil de Lyon, France
About: We are working with Hospices Civil de Lyon to measure nucleosome levels using the Nu.Q® NETs assay in septic shock patients.
Who: Santersus AG
About: We are working with Santersus AG, which is developing “NucleoCapture”, a transformational technology that cleanses blood of NETs as a sepsis treatment. They used Nu.Q® NETs within an animal study to measure treatment response and have moved to their ﬁrst human trial, with results due shortly.
Predict disease severity and support risk stratification
Monitor disease progression
Contact Nu.Q® NETs Team
Modal Contact Form (NETS)
"*" indicates required fields